摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(9-((2R,3R,5S)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-hydroxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide | 84138-86-3

中文名称
——
中文别名
——
英文名称
N-(9-((2R,3R,5S)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-hydroxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide
英文别名
N6-Benzoyl-5'-O-(dimethoxytrityl)-3'-deoxyadenosine;N-[9-[(2R,3R,5S)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-hydroxyoxolan-2-yl]purin-6-yl]benzamide
N-(9-((2R,3R,5S)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-hydroxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide化学式
CAS
84138-86-3
化学式
C38H35N5O6
mdl
——
分子量
657.726
InChiKey
MLTMJWMWEVDUAV-FNLMIIKUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    1.32±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.9
  • 重原子数:
    49
  • 可旋转键数:
    11
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.21
  • 拓扑面积:
    130
  • 氢给体数:
    2
  • 氢受体数:
    9

SDS

SDS:16cab4f3de360ce6c1033d1d6762b8b9
查看

制备方法与用途

N-苯甲酰基-5′-O-[双(4-甲氧基苯基)苯基甲基]-3′-脱氧腺苷是一种嘌呤核苷类似物,具有广泛的抗肿瘤活性,特别针对惰性淋巴系统恶性肿瘤。其抗癌机制主要依赖于抑制DNA合成和诱导细胞凋亡等过程[1]。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    O-Alkyl-5',5'-dinucleoside phosphates as prodrugs of 3'-azidothymidine and cordycepin
    摘要:
    The syntheses of two O-alkyl-5',5'-dinucleoside phosphotriesters 2a and 2b as combined prodrugs of the antiviral drug AZT (1) and the antibiotic agent cordycepin (3) are described. 2a,b were obtained as a 1:1 diastereomeric mixture. The absolute configuration of the isolated diastereomers was determined by NOE NMR experiments and correlated with the migration characteristics on silica gel as well as the P-31-NMR chemical shift. The conformational features of 2b(R) and 2b(S) were determined m deuteriated dodecylphosphocholine micelles in aqueous solution using 2D-NOESY spectra and shown to be dependent on the configuration at phosphorus. Additionally, all new compounds were tested for their antiviral activities in HIV-1-infected CEM C113 and H9 cell systems. Although all compounds were able to significantly inhibit the HIV-1-induced cytopathogenic effect, only the phosphodiester 12 gave a selectivity index (SI(RT) = 2000) comparable to the reference compound AZT (1) (SI(RT) = 3000).
    DOI:
    10.1021/jo00052a053
  • 作为产物:
    描述:
    N-{9-[(2R,3R,5S)-5-((R)-1,2-Dihydroxy-ethyl)-3-hydroxy-tetrahydro-furan-2-yl]-9H-purin-6-yl}-benzamide 在 吡啶 、 sodium tetrahydroborate 、 sodium periodate 作用下, 反应 14.5h, 生成 N-(9-((2R,3R,5S)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-hydroxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide
    参考文献:
    名称:
    Arslan, Tuncer; Abraham, Anil T.; Hecht, Sidney M., Nucleosides and Nucleotides, 1998, vol. 17, # 1-3, p. 515 - 530
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Improved procedure for the preparation of deoxynucleoside phosphoramidites: Arylphosphoramidites as new convenient intermediates for oligodeoxynucleotide synthesis
    作者:Jean-Louis Fourrey、Jeannette Varenne
    DOI:10.1016/s0040-4039(01)81480-5
    日期:1984.1
    A simplified procedure for the preparation of deoxynucleoside methyl- and arylphosphoramidites is described. Both types of phosphoramidites can be conveniently activated by N-methylaniline trifluoracetate for their use in oligodeoxynucleotide synthesis.
    描述了一种制备脱氧核苷甲基-和芳基磷酰胺的简化方法。两种类型的亚磷酰胺都可以方便地被N-甲基苯胺三氟乙酸酯活化,以用于寡聚脱氧核苷酸的合成。
  • LOCKED NUCLEIC ACID CYCLIC DINUCLEOTIDE COMPOUNDS AND USES THEREOF
    申请人:ADURO BIOTECH, INC.
    公开号:US20190185511A1
    公开(公告)日:2019-06-20
    The present invention provides highly active locked nucleic acid cyclic-dinucleotide (LNA-CDN) immune stimulators that activate DCs via the cytoplasmic receptor known as STING (Stimulator of Interferon Genes). In particular, the LNA-CDNs of the present invention are provided in the form of a composition comprising one or more cyclic dinucleotides that induce human STING-dependent type I interferon production, wherein the cyclic dinucleotides present in the composition have at least one 2′, 4′ locked nucleic acids within the cyclic dinucleotide.
    本发明提供了高活性的锁定核酸环二核苷酸(LNA-CDN)免疫刺激剂,通过细胞质受体STING(干扰素基因刺激剂)激活DCs。具体而言,本发明的LNA-CDNs以一种组合物的形式提供,该组合物包括一种或多种诱导人类STING依赖型I型干扰素产生的环二核苷酸,其中组合物中的环二核苷酸至少有一个2′, 4′锁定核酸。
  • [EN] CYCLIC DI-NUCLEOTIDE COMPOUNDS AS STING AGONISTS<br/>[FR] COMPOSÉS DI-NUCLÉOTIDIQUES CYCLIQUES EN TANT QU'AGONISTES DE STING
    申请人:MERCK SHARP & DOHME
    公开号:WO2017027645A1
    公开(公告)日:2017-02-16
    A class of polycyclic compounds of general formula (II), of general formula (II'), or of general formula (II"), wherein Base1, Base2, Y, Ya, Xa, Xa1, Xb, Xb1, Xc, Xc1, Xd, Xd1, R1, R1a, R2, R2a, R3a, R4, R4a, R5, R6, R6a, R7, R7a, R8, and R8a are defined herein, that may be useful as inductors of type I interferon production, specifically as STING active agents, are provided. Also provided are processes for the synthesis and use of compounds.
    提供一类多环化合物,其一般化学式为(II),一般化学式为(II')或一般化学式为(II"),其中在此处定义了Base1、Base2、Y、Ya、Xa、Xa1、Xb、Xb1、Xc、Xc1、Xd、Xd1、R1、R1a、R2、R2a、R3a、R4、R4a、R5、R6、R6a、R7、R7a、R8和R8a,这些化合物可能作为I型干扰素的诱导剂,特别是作为STING活性剂。还提供了合成和使用这些化合物的方法。
  • Phosphonate inhibitors of HCV
    申请人:Boojamra G. Constantine
    公开号:US20080107628A1
    公开(公告)日:2008-05-08
    A compound of Formula I, Formula II, Formula III, or Formula IV: or a pharmaceutically acceptable salt, solvate, and/or ester thereof, therapeutic compositions containing such compounds, and therapeutic methods that include the administration of such compounds.
    一种具有I式、II式、III式或IV式的化合物,或其药学上可接受的盐、溶剂和/或酯,包含这种化合物的治疗组合物,以及包括给予这种化合物的治疗方法。
  • Novel Poxin Stable cGAMP‐Derivatives Are Remarkable STING Agonists
    作者:Samuele Stazzoni、Daniel F. R. Böhmer、Fabian Hernichel、Dilara Özdemir、Aikaterini Pappa、David Drexler、Stefan Bauernfried、Gregor Witte、Mirko Wagner、Simon Veth、Karl‐Peter Hopfner、Veit Hornung、Lars M. König、Thomas Carell
    DOI:10.1002/anie.202207175
    日期:2022.10.4
    Dideoxy-cyclic-dinucleotide analogs of cGAS/STING second messenger 2′,3′-cGAMP are prepared using a new and concise synthetic combination of phosphoramidite and phosphotriester chemistry. The dideoxy analogs are found to exhibit remarkable in cellulo and in vitro properties, are stable against degradation by poxvirus immune nucleases, and exhibit superior tumor growth control in a mouse model.
    cGAS/STING 第二信使 2′,3′-cGAMP 的二脱氧环二核苷酸类似物是使用亚磷酰胺和磷酸三酯化学的新颖简洁的合成组合制备的。发现双脱氧类似物在纤维素和体外特性中表现出显着的特性,对痘病毒免疫核酸酶的降解保持稳定,并且在小鼠模型中表现出卓越的肿瘤生长控制。
查看更多

同类化合物

(3-三苯基甲氨基甲基)吡啶 非马沙坦杂质1 隐色甲紫-d6 隐色孔雀绿-d6 隐色孔雀绿 隐色乙基结晶紫 降钙素杂质10 酸性黄117 酸性蓝119 酚酞啉 酚酞二硫酸钾水合物 萘,1-甲氧基-3-甲基 苯酚,4-(1,1-二苯基丙基)- 苯甲醇,4-溴-a-(4-溴苯基)-a-苯基- 苯甲酸,4-(羟基二苯甲基)-,甲基酯 苯甲基N-[(2(三苯代甲基四唑-5-基-1,1联苯基-4-基]-甲基-2-氨基-3-甲基丁酸酯 苯基双-(对二乙氨基苯)甲烷 苯基二甲苯基甲烷 苯基二[2-甲基-4-(二乙基氨基)苯基]甲烷 苯基{二[4-(三氟甲基)苯基]}甲醇 苯基-二(2-羟基-5-氯苯基)甲烷 苄基2,3,4-三-O-苄基-6-O-三苯甲基-BETA-D-吡喃葡萄糖苷 苄基 5-氨基-5-脱氧-2,3-O-异亚丙基-6-O-三苯甲基呋喃己糖苷 苄基 2-乙酰氨基-2-脱氧-6-O-三苯基-甲基-alpha-D-吡喃葡萄糖苷 苄基 2,3-O-异亚丙基-6-三苯甲基-alpha-D-甘露呋喃糖 膦酸,1,2-乙二基二(磷羧基甲基)亚氨基-3,1-丙二基次氮基<三价氮基>二(亚甲基)四-,盐钠 脱氢奥美沙坦-2三苯甲基奥美沙坦脂 美托咪定杂质28 绿茶提取物茶多酚陕西龙孚 结晶紫 磷,三(4-甲氧苯基)甲基-,碘化 碱性蓝 硫代硫酸氢 S-[2-[(3,3,3-三苯基丙基)氨基]乙基]酯 盐酸三苯甲基肼 白孔雀石绿-d5 甲酮,(反-4-氨基-4-甲基环己基)-4-吗啉基- 甲基三苯基甲基醚 甲基6-O-(三苯基甲基)-ALPHA-D-吡喃甘露糖苷三苯甲酸酯 甲基3,4-O-异亚丙基-2-O-甲基-6-O-三苯甲基吡喃己糖苷 甲基2-甲基-N-{[4-(三氟甲基)苯基]氨基甲酰}丙氨酸酸酯 甲基2,3,4-三-O-苯甲酰基-6-O-三苯甲基-ALPHA-D-吡喃葡萄糖苷 甲基2,3,4-三-O-苄基-6-O-三苯甲基-ALPHA-D-吡喃葡萄糖苷 甲基2,3,4-三-O-(苯基甲基)-6-O-(三苯基甲基)-ALPHA-D-吡喃半乳糖苷 甲基-6-O-三苯基甲基-alpha-D-吡喃葡萄糖苷 甲基(1-trityl-1H-imidazol-4-yl)乙酸酯 甲基 2,3,4-三-O-苄基-6-O-三苯基甲基-ALPHA-D-吡喃甘露糖苷 环丙胺,1-(1-甲基-1-丙烯-1-基)- 溶剂紫9 溴化N,N,N-三乙基-2-(三苯代甲基氧代)乙铵 海涛林